Related Experiment Video
Updated: Aug 7, 2026

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
Defining the CD59-C9 binding interaction
Yuxiang Huang1, Fei Qiao, Ruben Abagyan
1Department of Microbiology and Immunology, Medical University of South Carolina, South Carolina 29403, USA.
Abstract:
CD59 is a membrane glycoprotein that regulates formation of the cytolytic membrane attack complex (MAC or C5b-9) on host cell membranes. It functions by binding to C8 (alpha chain) and C9 after their structural rearrangement during MAC assembly. Previous studies indicated that the CD59 binding site in C9 was located within a 25-residue disulfide-bonded loop, and in C8alpha was located within a 51-residue sequence that overlaps the CD59 binding region of C9. By peptide screens and the use of peptides in binding assays, functional assays, and computer modeling and docking studies, we have identified a 6-residue sequence of human C9, spanning residues 365-371, as the primary CD59 recognition domain involved in CD59-mediated regulation of MAC formation. The data also indicate that both C8alpha and C9 bind to a similar or overlapping site on CD59. Furthermore, data from CD59-peptide docking models are consistent with the C9 binding site on CD59 located at a hydrophobic pocket, putatively identified previously by CD59 mutational and modeling studies.
Insights
Researchers identified a specific 6-residue sequence in complement protein C9 that acts as the primary binding site for CD59. This finding clarifies how CD59 regulates the formation of the membrane attack complex (MAC).
Area of Science:
- Immunology
- Complement System Biology
Background:
- CD59 is a crucial membrane glycoprotein regulating the formation of the cytolytic membrane attack complex (MAC, or C5b-9).
- CD59 functions by binding to C8 (alpha chain) and C9 during MAC assembly, inhibiting its completion on host cell membranes.
Purpose of the Study:
- To pinpoint the precise region of human C9 responsible for CD59 recognition.
- To elucidate the interaction site of CD59 on C8alpha and C9.
Main Methods:
- Peptide screens and binding assays were employed to identify CD59 interaction domains.
- Functional assays and computer modeling, including docking studies, were utilized to analyze CD59-protein interactions.
Main Results:
- A 6-residue sequence (residues 365-371) in human C9 was identified as the primary CD59 recognition domain.
- Both C8alpha and C9 appear to bind to a similar or overlapping site on CD59.
- CD59-peptide docking models suggest C9 binds to a hydrophobic pocket on CD59.
Conclusions:
- The study precisely maps the CD59 recognition site on C9, advancing understanding of MAC regulation.
- The findings provide a molecular basis for CD59's inhibitory function in the complement cascade.
- This detailed interaction knowledge could inform therapeutic strategies targeting complement-mediated damage.
Related Concept Videos
The Equilibrium Binding Constant and Binding Strength
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ligand Binding and Linkage
